Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced dexamethasone prophylaxis around docetaxel in breast and prostate cancer
NL-OMON45067Phase 1Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of dexamethasone in breast cancer and prostate cancer (PCa) (10 arms), sponsored by Leiden University Medical Center. Primary endpoint: Recommended dexamethasone dose. Started Apr 2016; status: active, not recruiting.
02
Drugs
dexamethasone
03
Conditions
breast cancerprostate cancer (PCa)
Beyond the preview
Go deeper on NL-OMON45067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45067.